Podcasts about Commercialization

From Obamacare's limitations to the Bayh-Dole Act, Dr. Abramson reveals how commercial interests overtook public health priorities in research and care. #HealthcareReform #ProfitOverPatients #BayhDole

In this episode of Tank Talks, Matt Cohen sits down with Christian Weedbrook, founder and CEO of Xanadu, and Bill Fradin, CEO of Crane Harbor Acquisition Corp., to explore the historic SPAC merger that is bringing Xanadu to the public markets. With a focus on photonic quantum computing, Xanadu has rapidly advanced in the quantum tech space, positioning itself as a leader in both hardware and software innovation.The merger, which values Xanadu at $3 billion, will not only help accelerate the company's growth but also raise significant capital, enabling it to expand its groundbreaking quantum computing solutions. Christian and Bill dive into why they chose the SPAC route, the strategic value behind their merger, and what sets Xanadu apart in the competitive quantum ecosystem.In addition, the episode takes a deep dive into Xanadu's PennyLane software, which is already making waves in academia and the broader quantum community, and explores how the public market debut will position the company for future commercialization and innovation. Whether you're an investor looking to understand quantum tech's potential or someone interested in cutting-edge science, this episode is a must-listen.Introduction to Xanadu's Quantum Computing Vision (01:23)Christian Weedbrook gives a quick overview of Xanadu's mission to build useful quantum computers with their photonic modality using lidar photons. Learn how they're positioning themselves in both hardware and software through their PennyLane software stack.Xanadu's Decision to Go Public (04:09)Christian explains why going public was always part of Xanadu's strategy and how the company transitioned from private funding rounds to a SPAC merger, raising $275 million in just four weeks.Why Choose a SPAC (10:02)Christian and Bill discuss the advantages of a SPAC over traditional IPOs, particularly for deep-tech companies like Xanadu, where the usual metrics for IPOs aren't always applicable.The Power of PennyLane (14:43)Christian highlights the growing adoption of PennyLane, Xanadu's quantum software, which is already being used across 150 universities worldwide and growing. Learn how going public will further accelerate its adoption.Strategic Partnerships and the Path to Commercialization (16:20)Bill shares insights on how going public will help Xanadu expand its industry partnerships, including major players like Volkswagen and Rolls-Royce, and how these collaborations could lead to breakthroughs in areas like electric vehicle batteries and pharmaceuticals.Energy Efficiency and the Future of Quantum Computing (24:39)Christian explains how quantum computing can drastically reduce energy consumption in computing, using Xanadu's Borealis quantum computer as an example. This new approach promises significant energy savings, especially in industries like AI, drug discovery, and material design.Xanadu's Road Ahead in the Public Market (27:27)Christian reflects on the monumental journey Xanadu has been on, comparing it to the early days of the internet and digital computing. He also discusses how this milestone will change the company's trajectory and impact the quantum computing ecosystem.About Christian WeedbrookChristian Weedbrook is the founder and CEO of Xanadu, a leading quantum computing company based in Toronto. With a passion for quantum technology, Christian has spearheaded the development of Xanadu's groundbreaking photonic-based quantum computers. His leadership has positioned Xanadu as one of the pioneers in quantum computing, not only through its hardware advancements but also with the development of its PennyLane software platform. Christian's vision is to build quantum computers that are both useful and accessible to people around the world, and he is committed to driving forward the next era of quantum technology.Connect with Christian Weedbrook on LinkedIn: https://www.linkedin.com/in/christianweedbrook/Visit the Xanadu website: https://www.xanadu.ai/About Bill FradinBill Fradin is the CEO of Crane Harbor Acquisition Corp., a SPAC focused on identifying and merging with innovative companies in the tech sector. With over 20 years of experience in the financial industry, Bill has been at the forefront of numerous successful SPAC transactions, specializing in high-growth, disruptive technology companies. His leadership has been integral to bringing Crane Harbor to the public markets, and he has built a strong reputation for identifying companies with significant long-term potential. Bill's experience in both private and public markets has made him a trusted partner for visionary companies like Xanadu, helping them navigate the complexities of the SPAC process and positioning them for success in the public arena.Connect with Bill Fradin on LinkedIn: https://www.linkedin.com/in/bill-fradin-83196b3/Visit the Crane Harbor Acquisition Corp website: https://www.craneharboracquisition.com/Connect with Matt Cohen on LinkedIn: https://ca.linkedin.com/in/matt-cohen1Visit the Ripple Ventures website: https://www.rippleventures.com/ This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit tanktalks.substack.com

“Practicing yoga is not really something separate from me. It is happening all the time.” In this episode of a Curious Yogi Podcast, yoga teacher Myra Khanna shares her journey from Kathak dancer and scuba diving instructor to dedicated yoga practitioner and teacher. Drawing from studies with Bharath Shetty, Vinay Kumar, Vijay Kumar, Deepika Mehta, Mark Robberds, Eddie Stern, and ongoing training with Yoga Education College, Myra reflects on her evolution from a physically driven Ashtanga practice to a more holistic exploration of pranayama, meditation, and nervous system regulation.The conversation explores the commercialization of yoga, misconceptions about yoga in India, female health awareness in asana practice, and the parallels between diving and meditative practice. Myra also shares how traditional strength disciplines like mudgar swinging, dandas, and baithaks inform her approach to resilience and sustainability in practice.Here are some key takeaways; ➖ Transition from purely physical to a more holistic practice.➖ Emphasize the importance of listening to one's body and nervous system.➖ Commercialization of yoga impacts its true essence.➖ Teaching should accommodate students' individual needs and journeys.➖ Diving parallels the meditative aspects of yoga.➖ Myra's passion for education on female health in yoga after becoming unwell. Connect with Myra: IG @myrakhann02 I really enjoyed this conversation as an invitation to reconsider yoga as a living, evolving process — one rooted in curiosity, community, and embodied awareness. I know you will also dear listeners. In oneness, Bobbi Thanks for listening!

In this episode of The Syneos Health Podcast, Conversations on Commercialization, Tyler Cowan, VP, Commercial speaks with Paul Rittman, President and General Manager of Almirall US, about how payer consolidation and PBM influence are reshaping dermatology commercialization.   They discuss how pharmaceutical companies must adapt launch strategy, market access planning and clinical differentiation to succeed in today's competitive specialty landscape. The conversation explores the growing role of digital engagement, direct-to-consumer (DTC) strategy, telehealth and cash-pay models in improving patient access.   Listeners will gain practical insights into how innovation, payer strategy and patient-centric commercialization drive success in dermatology and specialty pharma.  The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Join us in this episode where we explore the latest in football controversies, psychological insights into players' behavior, and pressing societal issues like racism in sports. With lively debates, vibrant opinions, and detailed timestamps, this episode offers both entertainment and critical reflection.Arsenal's pursuit of quadruple amidst a competitive leagueRacism and racial abuse in European football, especially Vinicius Jr.'s incidentThe impact of club owners and managerial comments on societal perceptionsPlayer behavior, celebration etiquette, and on-field tensionsWorld Cup ticket pricing controversies and commercialization of footballCommentary on players' mental health, growth, and performance statistics00:00 - Introduction & Arsenal's season updates—top of the league and potential quadruple chase 01:13 - Manchester United's league standing and banter with rivals 02:47 - Valentine's Day celebrations and personal life updates 03:42 - Discussion on club holidays and work-life balance 04:45 - Addressing Valentine's plans and singlehood 05:36 - Support for clubs and fans' emotional investments 08:11 - Critical analysis of Manchester United's owner's comments on immigrants 09:42 - Racism in football: Vinicius Jr.'s racial abuse in Spain 13:26 - Champions League match between Benfica and Real Madrid—celebration and booing incident 15:33 - Incident of racial slurs during the game and Mourinho's comments 17:38 - Profound disappointment in Mourinho's stance; referee's role and on-field abuse 19:28 - Broader societal implications of racism and athlete responses 23:00 - Referee decisions and yellow card controversies in the game 25:20 - Stand with Vinicius Jr. and addressing racial abuse on and off the pitch 29:58 - In-depth debate on the interpretation of racial slurs, lip-reading, and bias 35:10 - Video evidence, reactions, and the importance of context in abuse accusations 36:44 - Player emotions, reactions, and the dynamics of team behavior during abuse incidents 41:07 - The importance of investigations and avoiding accusations without proof 44:26 - Commercialization of football: Players' roles versus corporate interests 45:14 - Societal perceptions of players' opinions outside football 48:40 - FA Cup updates, Chelsea, and Arsenal fixtures 55:05 - Player development, growth spurts, and stats analysis 61:44 - Promoting supportive community channels and personal endeavors 63:13 - Upcoming matches, league standings, and closing remarks

In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an introduction to the basics of radiopharmaceuticals.If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

In this Mission Matters episode, Adam Torres interviews Kevin McGovern, Chairman of McGovern Capital LLC, about his journey from investing in the stock market in seventh grade to building global brands like SoBe and mentoring the next generation of entrepreneurs through purpose-driven investing. About Kevin McGovern Kevin McGovern is Chairman and CEO of McGovern Capital, a New York–based single-family office that invests globally in innovative companies and strategic opportunities. Through McGovern Capital and its affiliates, he has co-founded over 25 companies, six of which became world or category leaders, and has served as lead negotiator in more than 15 international joint ventures across approximately 80 countries. McGovern was a founder of SoBe Beverages, helped popularize advanced water filtration technologies, and licensed skincare innovations used in ~40 % of products worldwide. He also serves on public and private boards, speaks internationally at academic and family office events, and has taught “Global Innovation and Commercialization” at top universities including Cornell, Stanford, MIT, and Harvard. About McGovern Capital LLC McGovern Capital LLC is a leading private investment firm and intellectual property strategist based in New York City, Greenwich, CT, and Miami, Florida. The firm originates, funds, structures, and implements capital formation as well as domestic and international joint ventures and business alliances, and provides early-stage capital and facilitative services to its portfolio companies. Through its global network, McGovern Capital and its affiliates have co-founded over 25 companies, including six category leaders such as SoBe Beverages and KX Industries, and have conducted business in approximately 80 countries. The firm specializes in go-to-market strategies for disruptive technologies and consumer-focused innovations, helping founders assess, strategize, and monetize intellectual property and business opportunities worldwide. Watch Full Episode On Youtube --- Follow Adam on Instagram at https://www.instagram.com/askadamtorres/ for up to date information on book releases and tour schedule. Apply to be a guest on our podcast: https://missionmatters.lpages.co/podcastguest/ Visit our website: https://missionmatters.com/ More FREE content from Mission Matters here: https://linktr.ee/missionmattersmedia Learn more about your ad choices. Visit podcastchoices.com/adchoices Learn more about your ad choices. Visit podcastchoices.com/adchoices

PREVIEW FOR LATER TODAY Guest: Bob Zimmerman. Zimmerman details Starfish's $154 million Pentagoncontract using space tugs to service and de-orbit satellites, highlighting the growing commercialization of low Earthorbit.1957

Atombeam CEO Charles Yeomans joins Chris Lustrino to break down a deceptively simple idea with massive implications: make data smaller while it's streaming so you can move and process more of it—without upgrading networks.Charles explains Atombeam's commercial product NeurPack, how it can often quadruple effective bandwidth, and why this matters across IoT, smart meters, satellites, defense, oil & gas wells, fintech, and eventually data centers and GPU utilization. They also dig into the realities of commercialization—choosing near-term deals that close fast while still pursuing multi-year “industry standard” opportunities—and why execution (not invention) is the real differentiator.00:00 What Atombeam does (pizza analogy)03:13 NeurPack explained05:35 Why 95% of IoT data doesn't move09:38 “Like launching 3 more satellites”13:57 Commercialization + customers16:31 Data centers + GPU utilization24:29 Defense traction + partnerships26:44 What success looks like (distribution)

NASA technology brings the golden age of exploration to Earth.

Neurologist Dr. Vinit Banga explains stress, sleep, stroke symptoms, brain health, and the effects of pollution on the brain in this powerful podcast episode with Gaurav Arora.This episode covers:•Stress symptoms and how chronic stress damages the brain•Deep sleep and why sleep is essential for brain repair•Stroke warning signs (FAST symptoms) and why minutes matter•Brain fog, memory loss, cognitive decline, early dementia signs•Delhi pollution / AQI effects on brain ageing and intelligence•Migraine triggers, headaches, and dangerous neurological red flags•Doctor-patient trust, Practo ratings, healthcare commercialization in India00:00 Impact of Delhi's Pollution on Brain Health00:37 Stress and Its Effects on Health01:39 Air Quality and Brain Aging03:24 Blood-Brain Barrier and Pollution06:03 Memory Issues and Aging07:04 Understanding Memory Formation12:20 Sleep Disorders and Brain Health13:35 The Importance of Deep Sleep16:09 Stress: The Silent Disruptor46:38 Doctor-Patient Trust and Ethical Concerns55:14 Commercialization in Healthcare01:04:15 Concluding Thoughts and GratitudeDr. Vinit Banga is Director & Head of Neurology & Neurovascular Intervention at Fortis Escorts, and shares life-saving insights on preventing stroke, protecting brain function, and understanding modern neurological risk factors.Keywords: neurologist podcast, brain health India, stress and stroke, sleep and brain, stroke symptoms, stroke warning signs, Delhi pollution brain damage, brain fog, dementia signs, migraine, Fortis neurologist, Dr Vinit Banga, Gaurav Arora podcast.#Stress #Stroke #BrainHealth #Sleep #Neurology #Podcast #DrVinitBanga

Episode 60: Revolutionizing and Democratizing Autonomous Driving  Alex Kendall, founder and CEO of Wayve, a UK-based company with $1.3 billion of funding from Microsoft, NVIDIA, Softbank and Uber, discusses Wayve’s head start in end-to-end AI for driving, its efficient training and run-time architecture, and its suitability to any car manufacturer.  00:00 Welcome to Tech Cars Machines  01:32 Introduction to Alex Kendall and Wayve  02:00 Wayve’s Autonomous Technology Explained  04:21 The End-to-End AI Approach  06:54 Wayve’s Data Efficiency and Learning  09:13 Alex Kendall’s Background and Journey  12:07 Wayve’s Path to Commercialization  23:22 Wayve’s Competitive Edge and Market Position  25:41 Adoption and Consumer Perception of Autonomous Vehicles  31:56 Customization and OEM Integration  35:51 Future of Autonomous Driving and Industry Impact 

Hello, hello! In this episode of the Good Garbage Podcast, host Ved Krishna sits down with Neha Jain, Founder & CEO of Zerocircle, to explore how seaweed-based materials could transform the future of sustainable packaging. Imagine a world where packaging doesn't end up stranded on beaches, but instead safely dissolves back into nature. That's the future Neha is working toward.Neha shares her journey from working at Google to building Zerocirlce, a company focused on developing natural polymer materials from seaweed as an alternative to plastic packaging. This conversation dives deep into material science, the challenges of scaling sustainable packaging solutions, and why true sustainability must work commercially, not just environmentally.Together, Ved and Neha discuss:- How seaweed is used to create home-compostable packaging materials- The science behind natural polymers and plastic alternatives- Why collaboration is critical in the sustainable materials ecosystem- What it takes to scale climate-positive solutions globally- Why “good garbage” means designing systems where waste doesn't existZerocircle's vision goes beyond packaging aiming to become a core material provider for manufacturers worldwide, helping reduce plastic waste at scale. → Find out more about Zerocirlce: https://www.zerocircle.in/

Disease accelerates years in a month. Cancer cells reveal which patients might be most impacted by metastasis - a diagnosis invisible on Earth. Single crystals heal themselves through mechanisms we can't explain. These aren't projections. They're validated results from 2022-2025 that made 40-year NASA veterans say they'd never seen anything like it.The economics flipped. Merck flew Keytruda 30 days, discovered a crystal form missed in a decade of labs - $20B/year by 2030, exceeding SpaceX's entire revenue. The thesis: Two paths to space affordability: cut launch costs 10x AND multiply payload value 1,000x. Do what Earth cannot do at any price.Paradigm Shifts:

Two companies have teamed up to develop a range of combined biotechnologies that will reduce the need for synthetic fertilizers in commercial agriculture.

In this episode of Longevity by Design, host Dr. Gil Blander sits down with Dr. Wei-Wu, Executive Chairman at Human Longevity, Inc. Together, they explore how advances in genome sequencing, AI, and multi-layered diagnostics are changing the fight against age-related diseases. Wei-Wu shares why understanding your own genetic risks and combining them with other health data leads to better prevention and a longer healthspan.Wei-Wu explains the value of integrating genome sequencing, advanced imaging, and liquid biopsy to catch diseases like cancer early, before symptoms appear. He draws on real-world examples, including how combining different tests can spot cancers that single methods might miss. The conversation highlights how technology brings down costs, making once-rare insights widely available, and how each person stands to benefit from personalized risk profiles.The episode closes with practical advice: use today's tools to become the CEO of your own health. Wei-Wu urges listeners to embrace data-driven, individualized care and stresses that no single tool or habit holds all the answers. Instead, true longevity comes from a holistic, ongoing approach, one that uses all available knowledge to prevent disease and extend both life and health.Guest-at-a-Glance

THE BLIP AND THE FUTURE Colleague Keach Hagey, The Optimist. The viral success of ChatGPT shifted OpenAI's focus from safety to commercialization, despite early internal warnings about the existential risks of AGI. Tensions over safety and Altman's management style led to a "blip" where the nonprofit board fired him, only for him to be quickly reinstated due to employee loyalty. Elon Musk, having lost a power struggle for control of the organization, severed ties, leaving Altman to lead the race toward AGI. NUMBER 16 FEBRUARY 1955

Pete Bigelow, Public Relations Manager, Kodiak joined Grayson Brulte on The Road to Autonomy podcast to discuss his firsthand experience in the Permian Basin and how the region acts as a "literal and figurative sandbox" for autonomous trucking.During the episode Grayson and Pete discuss Kodiak's operational partnership with Atlas Energy Solutions, the hardening of technology against extreme weather and road conditions, and how these industrial learnings are accelerating Kodiak's timeline for driverless highway operations in the second half of 2026.Episode Chapters0:00 Permian Pete3:50 Permian Basin8:02 Automation in the Permian Basin11:10 Learnings from the Permian Basin16:01 Permian Basin Operations18:49 SensorPods23:50 Kodiak's Diversified Business Model27:34 Autonomous Trucking Regulations30:15 Permian Basin Road and Traffic Conditions35:49 Permian Pete's Ride Experience41:31 Autonomy Markets OutlookRecorded on Friday, December 19, 2025--------About The Road to AutonomyThe Road to Autonomy provides market intelligence and strategic advisory services to institutional investors and companies, delivering insights needed to stay ahead of emerging trends in the autonomy economy™. To learn more, say hello (at) roadtoautonomy.com.Sign up for This Week in The Autonomy Economy newsletter: https://www.roadtoautonomy.com/ae/See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

A compilation of the top Fusion News stories from 2025, plus an overview of the year's major industry and policy advances by FIA CEO Andrew Holland. Thanks for tuning in with us all year! We look forward to covering more milestones in 2026.As always, links to the stories covered are included below.Late-breaking news: TAE Technologies merges with TMTGhttps://tae.com/trump-media-and-technology-group-to-merge-with-tae-technologies/Top stories of 2025:Laser-powered fusion experiment more than doubles its power outputhttps://techcrunch.com/2025/05/17/laser-powered-fusion-experiment-more-than-doubles-its-power-output/(Covered by Jeff on May 28)Google buys fusion powerhttps://www.thechemicalengineer.com/news/google-buys-fusion-power/(Jasmine, July 23)Helion Energy starts construction on nuclear fusion plant to power Microsoft data centershttps://www.reuters.com/business/energy/helion-energy-starts-construction-nuclear-fusion-plant-power-microsoft-data-2025-07-30/(Cyd, August 6)Commonwealth Fusion Systems Raises $863 Million Series B2 Round to Accelerate the Commercialization of Fusion Energyhttps://cfs.energy/news-and-media/commonwealth-fusion-systems-raises-863-million-series-b2-round-to-accelerate-the-commercialization-of-fusion-energy(Abdus, September 3)Germany bets billions on nuclear fusion for energy futurehttps://www.dw.com/en/nuclear-fusion-germany-bets-billions-on-technology-for-energy-future/a-74522109(Abdus, November 12)

Why Dec. 25? Why so much Christmas conflict & controversy in Christianity's history? Why is Christmas so important to Christianity? And to America? In this episode, I ask my guest, Dr. Carey Roberts, the following questions: ►Why is Christmas such a grand celebration? What does this tell us about Christianity? ►Did it take a while for Christmas to take a central role in Christianity►What's the difference between recognition and celebration of Christmas►Did Christmas piggyback on existing Roman pagan traditions? ►How did Christmas enter America's culture? If not the Puritans, then which immigrant group introduced Christmas to America? ►Were there any regional differences in the celebration of Christmas?►When did U.S. businesses begin to capitalize on Christmas? ►Would President Grant have witnessed a similar Christmas celebration in Boston and Savannah? ►Would George Washington recognize our Christmas? How about Andrew Jackson? Abraham Lincoln? Teddy Roosevelt? ►What happened to Christmas after WWII? ►Is it a bad thing that non-Christians and/or non-practicing Christians celebrate Christmas? ⁠

Sign up to New Wave's newsletter. ***This week on New Wave Weekly:

WHAT YOU NEED TO KNOWCertification secured, enabling global shipment of HPQ's ENDURA+ lithium-ion battery cellsProduction capacity targeted at up to 1.5 million batteries per yearBattery samples delivered to prospective customers, with active commercial discussions underwayInitial battery revenue targeted for early 2026HPQ Silicon is moving from laboratory validation to real-world commercialization at a pace few early-stage battery companies achieve. CEO Bernard Tourillon outlines how a critical regulatory milestone, early customer engagement, and federal backing are converging to open near-term revenue pathways for the company's silicon-enhanced lithium-ion batteries.“Projects like HPQ Silicon's strengthen Canada's ability to manufacture components for high-performance batteries, and are creating a world-class battery ecosystem. ” – The Honourable Tim Hodgson, Minister of Energy and Natural ResourcesHPQ recently secured UN38.3 certification for its ENDURA+ 18650 and 21700 lithium-ion cells. For investors, this is not a technical footnote. UN38.3 is the global safety standard required to ship lithium batteries by air, sea, or land. Without it, commercial sales at scale are impossible.Tourillon explains that this certification clears what he calls “the logistical barrier,” allowing HPQ to move from limited sampling to meaningful customer orders and global distribution.“On our first full test run, we had no issues at all. That gives a very high level of confidence that our battery infrastructure is doing things the right way.”With certification secured, HPQ now has the ability to ship batteries in volume and support customer testing programs that lead to production orders. Management has confirmed current manufacturing capacity of approximately 1.5 million cells per year, a meaningful starting point for niche but fast-growing markets.Key commercialization signals discussed in the interview include:Battery samples already shipped to potential customersActive discussions underway with multiple prospective buyersAt least one strategic customer described as “very close” to initial ordersManagement targeting the start of battery-related revenue in early 2026Tourillon emphasized that certification timing was deliberate. Rather than rushing to market, HPQ chose to fully validate safety and quality, reducing the risk of recalls or failures that have derailed competitors.HPQ is not chasing mass-market commodity batteries. Instead, it is targeting applications where performance, longevity, and supply-chain security matter most.Discussed end markets include:E-bikes and electric mobilityDrones and specialized industrial equipmentHandheld and professional-grade power toolsStationary energy storage systems using 18650 and 21700 cellsA recurring theme in the discussion was growing interest from customers seeking non-Chinese battery supply. According to Tourillon, geopolitical risk and supply-chain concentration are driving new conversations that did not exist even two years ago.One of the more important insights for investors was HPQ's shift toward selling finished batteries rather than only supplying silicon-based anode material. Tourillon noted that margins on battery cells are expected to exceed those achievable by selling materials alone.In simple terms, HPQ captures more value by controlling the final product while keeping the option open to partner with larger manufacturers in the future.HPQ's progress is reinforced by up to $3 million in Canadian federal funding to support battery manufacturing infrastructure. Management views this as both validation and leverage, enabling the company to pursue a hybrid strategy: selling batteries directly today while retaining flexibility to license materials or partner at scale later.

Pastor Femi, Esther, and Kenneth tackle the most debated question in church culture with biblical truth and unfiltered honesty. The answer might surprise you.In this episode, PF breaks down 1 Corinthians 8 "idols are nothing" and explains why Christmas shouldn't be the scapegoat for pseudo-spirituality. The crew explores Christian freedom, why believers judge each other over holidays, and how we major in the minors while missing what actually matters.From debating turkey wings as Christmas food to discussing "Dirty December" culture in Nigeria, this conversation mixes theology, humor, and cultural commentary. PF even shares his complex relationship with Christmas after losing his mother on December 25th yet still advocates for celebration without guilt.The bottom line: Celebrate or don't celebrate but stop using holidays as spiritual one-upmanship.

Nothing sounds more wholesome than kids and sports. But as legal scholar Dionne Koller illustrates youth sports have become increasingly commercial, unregulated, and competitive with companies, including private equity firms, replacing publicly-subsidized recreational programs. This highly lucrative industry profits from, among other things, clubs, camps, equipment, mega facilities, and youth sports tourism — exacting a high cost from families and even greater physical and mental cost from children. Dionne Koller, More Than Play: How Law, Policy, and Politics Shape American Youth Sport UC Press, 2025 Photo by Ben Hershey on Unsplash The post The Commercialization of Youth Sports appeared first on KPFA.

Hamza Akram Qawwal is a prominent Pakistani Sufi singer and composer leading the Hamza Akram Qawwal & Brothers ensemble, representing the 26th generation of the historic Qawwal Bachon ka Gharana of Delhi, known for reviving traditional qawwali with modern relevance, performing globally, and blending classical Persian/Urdu/Punjabi poetry with contemporary sounds. He trained under Ustad Naseeruddin Saami and Farid Ayaz Qawwal, bringing this ancient spiritual art to younger audiences. Chapters:0:00 Introduction1:00 History of Qawali8:57 Qawal Gharana14:27 Amir Khusrau19:07 Is Qawali haram?23:15 Jagjit Singh, Pakistan and India27:50 Nusrat Fateh Ali Khan and new age Qawali culture41:55 Original melodies and Qawalis48:00 Hamza Akram's journey56:35 Idea of Ishq in Sufism and Peer-Mureed ka rishta1:05:32 How Hamza Akram became a Qawal and understanding Sufi Poetry 1:27:00 Understanding Music, Raag and Frequencies, and performing concerts1:36:00 Coke Studio, Pakistan Idol and Commercialization of Music1:39:15 Audience QuestionsThe Pakistan Experience is an independently produced podcast looking to tell stories about Pakistan through conversations. Please consider supporting us on Patreon:https://www.patreon.com/thepakistanexperienceTo support the channel:Jazzcash/Easypaisa - 0325 -2982912Patreon.com/thepakistanexperienceAnd Please stay in touch:https://twitter.com/ThePakistanExp1https://www.facebook.com/thepakistanexperiencehttps://instagram.com/thepakistanexpeperienceThe podcast is hosted by comedian and writer, Shehzad Ghias Shaikh. Shehzad is a Fulbright scholar with a Masters in Theatre from Brooklyn College. He is also one of the foremost Stand-up comedians in Pakistan and frequently writes for numerous publications. Instagram.com/shehzadghiasshaikhFacebook.com/Shehzadghias/Twitter.com/shehzad89Join this channel to get access to perks:https://www.youtube.com/channel/UC44l9XMwecN5nSgIF2Dvivg/join

Send us a textFew people enter the MedTech world because of a personal experience with the technology itself—but for Brent Lavin, that's exactly where it began. At just 23 years old, a CT scan that revealed an urgent medical issue also sparked a lifelong passion for medical technology and its power to save lives. That moment became the foundation of a career devoted to driving innovation in healthcare.Brent's early engineering work revealed an exceptional talent for connecting technical possibility with human need. Over the next two decades, he would lead cross-functional teams through more than 20 successful product launches, three mergers and acquisitions, and hundreds of millions of dollars in portfolio growth. His leadership—marked by curiosity, clarity, and conviction—has earned him accolades such as BD's Director of the Year and the CEO Excellence Award.Today, as Director of Strategic Growth at BD, Brent is responsible for identifying high-impact opportunities for both organic development and targeted acquisitions. Previously, he served as Director of Marketing and Product Management, where he led global teams across multiple disease states to record-breaking revenue growth, even in the face of pandemic-era supply chain challenges.Before joining BD, Brent spent years at GE Healthcare, where he honed his product management and global commercialization expertise, launching next-generation ultrasound systems that achieved over 200% year-over-year growth. His career reflects a rare blend of technical grounding, marketing strategy, and human-centered leadership—built on a mission to deliver meaningful innovation to clinicians and patients worldwide.Beyond the numbers, Brent is known for building high-performing teams and mentoring leaders who thrive in complex environments. Whether he's shaping go-to-market strategies, integrating newly acquired companies, or guiding engineers toward greater clarity and impact, his approach is grounded in purpose: to help people and teams reach their full potential while bringing life-changing technologies to market. LINKS:Guest LinkedIn: https://www.linkedin.com/in/brent-lavin/ Aaron Moncur, hostDownload the Essential Guide to Designing Test Fixtures: https://pipelinemedialab.beehiiv.com/test-fixtureAbout Being An Engineer The Being An Engineer podcast is a repository for industry knowledge and a tool through which engineers learn about and connect with relevant companies, technologies, people resources, and opportunities. We feature successful mechanical engineers and interview engineers who are passionate about their work and who made a great impact on the engineering community. The Being An Engineer podcast is brought to you by Pipeline Design & Engineering. Pipeline partners with medical & other device engineering teams who need turnkey equipment such as cycle test machines, custom test fixtures, automation equipment, assembly jigs, inspection stations and more. You can find us on the web at www.teampipeline.us

On today's episode, we hear from the two St. Louis entrepreneurs who made this collaboration happen: Kevin Lemp, owner of 4 Hands Brewing Co., and Bob Koplar, who manages the Voltron franchise that his father created. In developing a special Voltron beer, they've launched a creative partnership that is both commercially successful and a whole lot of fun. In today's episode, Voltron Beer and balancing creativity with commercialization. Special Guests: Bob Koplar and Kevin Lemp.

In this episode of Plugged In, we bring you a panel discussion at the recent SED Forum Fall on the growing importance of energy resiliency as a strategic imperative. The panel, moderated by Melissa Heim, Principal of Commercialization and Development at Constellation, features Levi Love, Manager of Energy Procurement and Analytics at Sheetz, Scott Czubkowski, National Director of Energy and Facility Performance at Medxcel, and Abhinav Krishna, Vice President of Commercialization and Development at Constellation. This panel of experts explores how organizations across sectors are designing resilient and sustainable energy strategies to withstand disruptions and ensure business continuity. They discuss approaches including leveraging data and analytics for operational insights and integrating behind-the-meter and front-of-the-meter solutions. The panelists also share how innovations like battery technology, AI, and long-range data networks are shaping the future of energy resiliency, and why combining sustainability with reliability is essential for building a stronger, more adaptive energy future. You will want to hear this episode if you are interested in… ● Energy resiliency and its growing importance (01:30) ● Macro trends shaping energy resiliency strategies (02:51) ● Sheetz's approach to energy resilience and sustainability (04:41) ● Medxcel's healthcare-focused resiliency strategy (06:27) ● The ROI of resilience through cross-departmental data (09:43) ● On improving data accuracy and real-time insights (10:45) ● Behind-the-meter and front-of-the-meter solutions (14:15) ● Emerging technologies in healthcare energy systems (17:40) ● On battery technology and AI-powered energy analytics (19:55) ● AI, and the evolution of small modular reactors and long-duration storage (21:11) For full episode show notes, click here. Connect with Constellation Follow Constellation on LinkedIn Follow ChuckHanna on LinkedIn Follow Abinav Krishna on LinkedIn    Follow Raj Bazaj on LinkedIn Learn more about Constellation sustainability solutions Connect With Smart Energy Decisions Smart Energy Decisions Follow us on LinkedIn Subscribe to Smart Energy Voices on Apple Podcasts, Google Podcasts, Android, Spotify, Stitcher, TuneIn Radio, aCast, PlayerFM, iHeart Radio If you're interested in participating in the next Smart Energy Decision Event, visit smartenergydecisions.com or email our Community Development team at attend@smartenergydecisions.com

Bayer is reshaping its pharmaceutical business with a new operating model designed to enhance collaboration and bring research & development and commercialization closer together. In a recent episode of The Top Line podcast, Bayer executives Christine Roth, Executive Vice President and Head of Global Product Strategy and Commercialization, and Dr. Yesmean Wahdan, Head of Medical Affairs for the United States and North America, discussed how the company’s Dynamic Shared Ownership framework is driving faster innovation and helping accelerate the development of new therapies for patients. The model removes traditional hierarchies, empowers cross-functional teams and encourages real-time collaboration across departments. Roth and Wahdan said the approach has already shortened regulatory timelines, reduced resource use and helped deliver treatments to patients sooner. By embedding commercial insights early in the research process, Bayer teams can anticipate market needs and focus on the greatest areas of unmet medical demand. The leaders said the company’s collaborative culture keeps patient benefit at the center of decision-making. To learn more about how Bayer’s model is transforming its pipeline, listen to the full episode of The Top Line. See more from Bayer’s Christine Roth and Dr. Yesmean Wahdan on their LinkedIn profiles below: Christine: https://www.linkedin.com/in/christine-roth-34b07b18/ Yesmean: https://www.linkedin.com/in/yesmean-h-wahdan-md-71409b199/ See omnystudio.com/listener for privacy information.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed. What if drug naming could be faster, smarter and more aligned to brand strategy? In this episode, Addison Whitney's Joe Daley, President, and Bill Purdy, SVP and Managing Director of Global Brand Development & Strategy, break down how Ari™, a purpose-built AI platform, is solving long-standing naming and branding challenges in biopharma. Listen and you'll learn: How Ari™ integrates strategic input, trademark search and POCA screening Ways AI reduces attrition and regulatory risk in naming Why naming is now a strategic process and not just a creative one The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Oliver Peck and Greg Puciato discuss Better Lovers, Wealth Disparity, The Commercialization of Art and much more... Greg Puciato: Instagram WebsiteJoin our WITD membership program to get access to perks and FREE STUFF:https://www.youtube.com/channel/UCwbve_UjJGYkhio5lEBfSTw/joinOliver Peck:Email your questions... whatintheduckpodcast@gmail.comCameo: https://www.cameo.com/oliverpecker?qid=1731962713&aaQueryId=e538a3265a26fbd2ffa7561fbaab83a1Spotify: https://open.spotify.com/show/3YEUydeJPp3EbUnfkGc50ERumble - https://rumble.com/c/c-6067391Instagram - https://www.instagram.com/oliverpecker/Facebook - https://www.facebook.com/oliverduckypeckerTwitter - https://twitter.com/OLIVER_PECKer?ref_src=twsrc%5Egoogle%7Ctwcamp%5Eserp%7Ctwgr%5EauthorWebsite - https://www.oliverpeckpodcast.comSponsors:Anchor Screen Printing https://www.anchorscreenprinting.comElm Street Tattoo: https://www.elmstreettattoo.com/Cheap Thrills Clothing Brand: https://www.anchorscreenprinting.com/cheap-thrillsYellow Rose Canyon: https://www.yellowrosecanyon.com/Dream Machines of Texas https://www.dreammachinesoftexas.comLegacy Ink email: Legacyartsupplies@gmail.com**WITD Podcast is produced by: Audra Cabral & John NiederkornSound / Video by: Courtney Larkins**

Send us a textHealthcare is drowning in messy, inconsistent data, and IMO Health is helping clean it up so organizations can turn information into real clinical insight.In this CareTalk Executive Feature episode, host David E. Williams speaks with John Laursen, Senior Vice President of Commercialization at IMO Health, about how to separate hype from real value in AI healthcare.

Europe leads the world in discovery — yet too often, its breakthroughs never become global companies.Billions in research funding turn into patents, not products.While others build empires from ideas, Europe risks becoming the world's laboratory — brilliant, but broke.That's the paradox at the heart of this conversation.In this episode, Karl Nehammer, Vice-President of the European Investment Bank (EIB) and former Chancellor of Austria, joins Christian Soschner live at BIO-Europe 2025 to discuss how Europe can turn its world-class science into world-class companies.He shares how leadership forged in crisis can rebuild confidence, competitiveness, and growth — and why every crisis hides an opportunity to start thinking differently.

Liz is joined on the podcast by Becky Lai, Chief Strategist and VP of Marketing, to talk about the true North Star of commercialization: standard of care. Their discussion reframes success as more than building a product—it's about building a market where the product is trusted, adopted, and indispensable. Together, they explore how purposeful training, meaningful KOL engagement, and a clear strategic vision accelerate adoption and move technologies from launch to lasting impact.In 2025, we're embarking on a MedDevice Training Journey: From clinical trials to standard of care. Join us all year long as we explore training at each stage of the product life cycle.Need help developing your clinical trial training strategies? Contact us at training@cumbyconsulting.com.Related Resources:Rebecca Lai is the Chief Strategist and Marketing Executive at Rebecca Lai Consulting. She is a strategy and commercial executive with over 20 years of experience in medical and health technology companies, ranging from venture-backed startups to Fortune 200 corporations. As a dynamic strategic operator specializing in go-to-market, commercialization, and innovative business strategies, she has consistently driven double-digit growth and scaled new businesses with global impact. With a strong background in devices, diagnostics, and the digital transformation of healthcare, Rebecca has a proven track record of pioneering disruptive solutions across the continuum of care. Most recently, she was VP of Corporate Development and Strategy at iRhythm Technologies (NASDAQ:IRTC), a digital healthcare provider of cardiac monitoring services. She began her career at Medtronic (NYSE:MDT), where she held progressive global leadership roles in sales and marketing. Rebecca is recognized for her ability to navigate complexity and her data-driven, customer-centric approach to creating value and delivering cutting-edge products and services to patients worldwide. She holds a BSE and MSE in Bioengineering from the University of Pennsylvania and serves on the advisory board for Diversity by Doing Healthtech.Subscribe to our newsletter to hear more about the journey from clinical trials to standard of care! Click here to subscribe! Connect with us on LinkedIn: ⁠⁠⁠⁠⁠⁠⁠⁠⁠Rebecca Lai⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Cumby Consulting⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Rachel Medeiros⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Liz Cumby⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠About Cumby Consulting:Cumby Consulting's team of professionals deliver innovative MedTech training services for physicians, sales representatives, teaching faculty, key opinion leaders and clinical development teams. Whether you need a complete training system developed to deliver revenue sooner or a discrete training program for a specific meeting, Cumby Consulting will deliver highly strategic, efficient programs with uncompromising standards of quality.

Send us a textWhat is a “Spiritual Rut”?What are some signs that we are in a spiritual rut?Is being in a rut always bad?  What ruts could be considered good or safe?How can we discern if the rut is a “refining season allowed by God” or a “self-inflected” stall in our walk with Christ?How do we get out of those self-inflected ruts?What do we do during those “refining season” ruts?Are spiritual ruts ever caused by a lack of knowing God's will for our lives?  Are there biblical examples of men being in a spiritual rut?  Who?www.LeagueOfLogic.com

In this episode of Investor Connect, Hall Martin chats with Tim Raines, founder and CEO of Rare Innovation, a boutique consultancy that serves as an outsourced executive team for deep tech startups. Tim shares his extensive experience in science and technology commercialization, helping startups transition from research phases to market-ready products. With expertise in creating go-to-market strategies, product development, and compelling pitch decks, Tim has been pivotal in assisting startups to secure funding and achieve market traction. He discusses the importance of founders making the first sale, early market validation, and adapting communication for various stakeholders, from investors to end-users. Tim also underscores the importance of partnerships and strategic collaborations in navigating limited-resource environments and ensuring successful product commercialization. For founders and investors interested in deep tech, Tim offers valuable insights into the current trends and pitfalls in the ecosystem.    Visit Rare Innovation at Reach out to at   _______________________________________________________ For more episodes from Investor Connect, please visit the site at:    Check out our other podcasts here:   For Investors check out:   For Startups check out:   For eGuides check out:   For upcoming Events, check out    For Feedback please contact info@tencapital.group    Please , share, and leave a review. Music courtesy of .

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  In this episode, recorded at Fierce Pharma Week 2025, Tyler Cowan, VP Commercial at Syneos Health, joins Hruta Shah, Senior Engagement Manager for Syneos Health Consulting, to break down the high-stakes race in obesity treatment and the commercial boom around GLP-1 therapies.  You'll hear: What emerging launch strategies look like in a crowded, competitive pipeline and how success is being redefined How GLP-1s are accelerating a shift in stakeholder dynamics, including telehealth, large employers and direct-to-patient platforms Why traditional DTC advertising is evolving and how informed patients are influencing brand messaging The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Early detection saves lives, but today's tools are often invasive, slow, or used too late. In this episode, Breath Diagnostics CEO Ivan Lo explains how a non-invasive breath test can detect volatile organic compounds (VOCs) associated with disease—positioning breath as a first-line screen for early-stage lung cancer and potentially pneumonia and TB. We cover the science (why breath can capture near real-time biological change), sensitivity/specificity signals from 800+ patients, and a go-to-market/regulatory plan that prioritizes post-op pneumonia (shorter trials, no entrenched standard of care) before lung cancer screening. We also discuss platform economics (low-cost disposables, existing LC-MS infrastructure), trial scale and cost, and how breath could support ongoing monitoring after treatment. Investors get a clear view of timelines, risks, and upside; founders get lessons on platform positioning, capital efficiency, and sequencing indications. Highlights include...Why breath (VOCs) can surface disease signals minutes–hours after biological changeFirst-line screening thesis vs. liquid biopsy and CT workflowsEarly data: ~94% sensitivity / 85% specificity across 800+ patients (lung cancer context)Regulatory path: post-op pneumonia first (faster FDA route), lung cancer nextUnit economics: low-cost cartridge + existing LC-MS labs (hub-and-spoke)Clinical design: trial scale, costs, and companion-diagnostic “cocktail” potentialPlatform beyond oncology: pneumonia, TB, inflammation, RUO for pharmaChapters00:00 Intro & why early detection needs a rethink00:47 What Breath Diagnostics does (the “breath bag”)03:34 VOCs 101: why breath can be earlier than blood06:41 First-line screen vs. confirmatory tests08:19 Will this be ubiquitous at annual visits?11:53 Commercialization path & funding realities12:37 Pneumonia first: faster FDA route14:09 Lung cancer timeline & business model15:34 Hospital economics & pneumonia savings18:24 Trial scale/costs; disposable chip economics20:34 Team, funding strategy, and sequencing22:08 Early data and a “false negative” biopsy case24:12 TAM & eligibility (20M Americans qualify)25:06 What success looks like (2–3 years)27:00 Investor closing thoughts

Michael chats with Kathy Lee-Sepsick, CEO and Founder of Femasys. Together, they discuss the founding of Femasys and the products it offers, how Kathy has gone about raising capital for a women's health company despite a challenging lack of sector investment, the importance of gathering thorough safety data for regulatory approvals and commercialization, how Kathy envisions the global commercialization rollout for FemaSeed and FemBloc in the coming months, and much more. To learn more about Femasys and its products, visit Femasys.com.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  Recorded at Fierce Pharma Week 2025, the series begins with a two-part conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard joins host Tyler Cowan, VP, Commercial at Syneos Health to unpack how the pandemic reshaped provider expectations and the continued impact on commercial teams. From feedback loops to content fatigue, to the myth of multichannel mastery, they break down what it takes to engage HCPs on their terms. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

A new limited series of the Syneos Health Podcast, Conversations on Commercialization unpacks how biopharma leaders are rewriting the commercial playbook, redefining what it takes to succeed.  Recorded at Fierce Pharma Week 2025, the series continues with part two of our conversation with Mark Bard, co-founder of the Digital Health Coalition. In this episode, Bard and host Tyler Cowan turn the lens to patients, exploring how direct-to-patient models are disrupting traditional care and the implications of reduced physician involvement. They also tackle the rise of agentic AI, what it could enable and what commercial teams should be thinking about now. The views expressed in this podcast belong solely to the speakers and do not represent those of their organization. If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you'll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision-making and investment. You can find it all at https://www.syneoshealth.com/insights-hub. Like what you're hearing? Be sure to rate and review us! We want to hear from you! If there's a topic you'd like us to cover on a future episode, contact us at podcast@syneoshealth.com.

Bruce Alderman CEO, ROTEC USA | Water Industry Leader | Expert in Commercialization, Sales, and Process Innovation Bruce J. Alderman is a passionate, process-driven leader with a proven record of bringing disruptive water technologies to global industrial and municipal markets. Over his 25+ year career, Bruce has combined technical expertise with commercial insight to drive…More

In this episode, we chat with Diana Leon-Boys— Assistant Professor of Media and Cultural Studies at the University of Wisconsin-Madison's Department of Communication Arts—about her lifelong work examining the navigation of girlhood through a Latinx lens. Her book Elena, Princesa of the Periphery: Disney's Flexible Latina Girl extends conversations about minority representation and the complex relationship it has with child development. We host a dialogue between Diana's research and Henry's observations about boyhood in his book Where the Wild Things Were: Boyhood and Permissive Parenting in Postwar America. We discuss how both scholars pull from their own personal experiences growing up in America and how they interacted with their childhood media. We explore how the proliferation and production of children's and family media shape ideas of adolescence. Diana and Henry relate this back to their roles as parents within an ever-evolving media landscape where funding for educational children's content is dwindling. They further discuss how representation within media has changed over time and minority groups' relation to it. This is where Diana brings in her newer projects about depictions of Quinceañeras and Día de los Muertos in TV and films. We are left to ask what the politics of childhood are and what reforms can be done with current children's media.Here are some of the references from this episode, for those who want to dig a little deeper:Academic TextsDiana Leon-Boys:Elena, Princesa of the Periphery: Disney's Flexible Latina GirlQuinceañeras: Latinidades and Girlhood in Popular CultureHenry Jenkins:Where the Wild Things Were: Boyhood and Permissive Parenting in Postwar AmericaThe Children's Culture Reader“Just a Spoonful of Sugar: Permissive Child-Rearing and Walt Disney's Mary Poppins”“‘You've Got to Be Carefully Taught': The Whiteness of Permissive Culture”MIT Salute to Doctor SeussInterview about the bookOthers:Centuries of Childhood: A Social History of Family LifeKids in the Middle: How Children of Immigrants Negotiate Community Interactions for Their FamiliesLatina Teenhood: Intersectionalizing subjectivities in the post-network era.Crafting Public Opinion: The Effectiveness of China's Media Control Policies under Xi JinpingMade to Play House: Dolls and the Commercialization of American Girlhood, 1830-1930 Advice Books:The Common Sense Book of Baby and Child CareDare to Discipline  People, Places, Toys, and HolidaysPhilippe ArièsDr. Vikki KatzDía de los MuertosQuinceañerasBenjamin SpockMargaret MeadDr. SeussFred RogersStephanie PérezRaquel Reyes [American Girl Doll]Samantha Parkington [Doll]Julie AndrewsWalt DisneyDisneyland and Disney WorldPaper DollsFDRSigmund Freud Shows, Films, and Other MediaPee-wee's PlayHouseDennis the Menace [59-63' show, Comics]Leave It To BeaverThe Cosby ShowOne Piece [Anime, Manga, Live Action]Disney+EncantoCocoSnow White [Animated, Live Action]Little Mermaid [Animated, Live Action]Chinese State Media sounded like Fox MediaRogue OneSesame StreetGordita ChroniclesBaker and the BeautyBlueyDescendants film franchiseOn My BlockWednesdayMary PoppinsSaludos AmigosHarry Potter film seriesDora The Explorer The 5000 Fingers of Dr. T.Mad Magazine Classic IllustratedGabby's DollhouseQuinceañeras episodesSuper Sweet 16Wizards of Waverly PlaceDora the Explorer  NewsDefunding of PBS Quinceañeras in ProtestOne Piece Flags in Indonesia ––––––––––––––––––––––––––––––Share your thoughts via Twitter with Henry, Colin and the How Do You Like It So Far? account! You can also email us at howdoyoulikeitsofarpodcast@gmail.com.Music:“In Time” by Dylan Emmett and “Spaceship” by Lesion X.In Time (Instrumental) by Dylan Emmet https://soundcloud.com/dylanemmetSpaceship by Lesion X https://soundcloud.com/lesionxbeatsCreative Commons — Attribution 3.0 Unported — CC BY 3.0Free Download / Stream: https://bit.ly/in-time-instrumentalFree Download / Stream: https://bit.ly/lesion-x-spaceshipMusic promoted by Audio Library https://youtu.be/AzYoVrMLa1Q––––––––––––––––––––––––––––––

Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1963

Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1959

CBS EYE ON THE WORLD WITH JOHN BATCHELOR 1914 BRUSSELS THE SHOW BEGINS IN THE EMERGENCY MEETING IN BRUSSELS ABOUT THE DRONES HARASSING THE EU...... 9-25-25 FIRST HOUR 9-915 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 915-930 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 930-945 Chris Riegel reports the US leads in AI infrastructure, having over 5,000 advanced data centers, compared to China's 500. China lags due to chip bans, recognizing that data is the new oil. 945-1000 Mary O'Grady reports a Tabasco scandal linking former president AMLO's Morena party and political allies to former security minister Bermúdez, now jailed as an alleged mob boss. SECOND HOUR 10-1015 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1015-1030 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1030-1045 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1045-1100 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. THIRD HOUR 1100-1115    Veronique de Rugy defines industrial policy as central planning using subsidies and tariffs to shape the economy. She argues the US already succeeds best through limited government and free trade principles. 1115-1130 Michael Bernstam explains Russia bypasses US sanctions via balanced ruble-yuan barter trade with China. As a vital energy exporter, punishing Russia's major oil buyers risks ending the world economy. 1130-1145 Cliff May describes wealthy Qatar hosting Hamas leaders, supporting the Muslim Brotherhood, and using Al Jazeerafor sophisticated propaganda. The US tolerates this due to its largest overseas air base in Doha. 1145-1200 Ahmad Sharawi discusses Syria's Al Sharah speaking at the UN seeking sanctions relief and international legitimacy, claiming victory over Assad. He addressed Captagon and accountability, though true judicial reforms are questioned. FOURTH HOUR 12-1215 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1215-1230 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1230-1245 Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1245-100 AM Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. CBS EYE ON THE WORLD WITH JOHN BATCHELOR THE SHOW BEGINS IN THE EMERGENCY MEETING IN BRUSSELS ABOUT THE DRONES HARASSING THE EU...... 9-23-25 FIRST HOUR 9-915 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 915-930 Anatol Lieven discusses Trump's UN speech suggesting Europe fund Ukraine war, sparking fear of US disengagement. Escalating Russian drone incidents serve as warnings, while UK politics remain unsettled. 930-945 Chris Riegel reports the US leads in AI infrastructure, having over 5,000 advanced data centers, compared to China's 500. China lags due to chip bans, recognizing that data is the new oil. 945-1000 Mary O'Grady reports a Tabasco scandal linking former president AMLO's Morena party and political allies to former security minister Bermúdez, now jailed as an alleged mob boss. SECOND HOUR 10-1015 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1015-1030 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1030-1045 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. 1045-1100 Evan Ellis analyzes South America's deep corruption, violence, and institutional crises across Peru, Venezuela, Brazil, and Colombia. China gains influence amidst anti-US political sentiment and rising illicit activities. THIRD HOUR 1100-1115    Veronique de Rugy defines industrial policy as central planning using subsidies and tariffs to shape the economy. She argues the US already succeeds best through limited government and free trade principles. 1115-1130 Michael Bernstam explains Russia bypasses US sanctions via balanced ruble-yuan barter trade with China. As a vital energy exporter, punishing Russia's major oil buyers risks ending the world economy. 1130-1145 Cliff May describes wealthy Qatar hosting Hamas leaders, supporting the Muslim Brotherhood, and using Al Jazeerafor sophisticated propaganda. The US tolerates this due to its largest overseas air base in Doha. 1145-1200 Ahmad Sharawi discusses Syria's Al Sharah speaking at the UN seeking sanctions relief and international legitimacy, claiming victory over Assad. He addressed Captagon and accountability, though true judicial reforms are questioned. FOURTH HOUR 12-1215 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1215-1230 Paul Mueller critiques industrial policy's resurgence, noting proponents conflate it with pro-market growth. He argues government direction leads to overproduction and resource misallocation, referencing China's EV troubles. 1230-1245 Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience. 1245-100 AM Ben Roberts and David Livingston detail microgravity's potential for medical breakthroughs (retinas, drugs) and advanced materials (semiconductors). Commercialization is nascent, supported by NASA grants, but requires long-term investor patience.

Rohit Nuwal is a Partner at TELUS Global Ventures, Canada's largest and most active corporate venture capital fund, with over 100 investments across transformative sectors such as HealthTech, AgTech, IoT, and AI. In this episode, we explore TELUS' unique approach to commercialization beyond capital — and how they leverage deep insights from their global businesses to provide investment partners with a pathway to real-world traction and growth. Rohit shares how their Strategic Portfolio Development team, combined with a distinctive incentive structure within the core business, accelerates adoption — generating over $100M in P&L value.

Marriage Contracts: The Sunset Clause Debate sparks a deep dive into the controversial trend of sunset clauses in marriage contracts. Are these renewal clauses a smart way to encourage growth and communication, or do they undermine the sanctity of marriage as a lifelong commitment? We explore the pros, cons, and real-world examples of couples who incorporate these clauses—and their potential impact on relationships. Is this the future of marriage or a fleeting experiment? Join the conversation, share your thoughts, and let us know where you stand on this provocative topic! Get Mobile Marriage Coaching with the Married Into Crazy® App at the Apple App Store or Google Play  #ships #creativewriting #relationshipadvice #mediation #familylaw  CHAPTERS: 00:00 - What is a Sunset Clause 04:22 - Example 1: Driver's License Expiration 10:05 - Example 2: Expiration Date Explained 10:55 - Sunset Clause for Wealthy Individuals 18:18 - Impact of Sunset Clause on Work Ethic 21:05 - Consequences of Not Renewing 21:14 - Marriage as a Contract: Communication vs. Commercialization 23:46 - Closing Remarks 24:48 - Reduced Episode Frequency Announcement

Pittsburgh's success in the robotics space didn't happen overnight. It's been over 40 years in the making, with education, business, and new innovations all coming together to make the city one of the big robotics hubs alongside Boston and San Francisco.The Pittsburgh Robotics Network has been a key player in that success, giving individuals, companies, and universities the opportunity to collaborate on projects and business opportunities. Executive Director, Jennifer Apicella, joins us on the podcast to give us a background on Pittsburgh's industry and to share her take on the commercialization of robotics and automation.A key theme in this episode is how you don't have to replicate the success of the big cities. Every place is different, and part of Pittsburgh's success has been to lean into its unique strengths and industry challenges. In other words, you don't need your city to become the next Silicon Valley to be successful. In this episode, find out:A recap of the great bars, restaurants and bowling alleys we explored around PittsburghJennifer explains what the Pittsburgh Robotics Network does and how it's helping to support new technology and industry growthSome background on why the Pittsburgh Robotics Network was started and built by the community it now representsHow the group measures success and why commercialization is key to developing technologies that solve real problemsHow other cities and regions can learn from what Pittsburgh has done without needing to copy the same formulaThe challenges of working in a non-profit in a for-profit industry and how Jennifer balances different prioritiesJennifer's advice for becoming a better part of the local technology communityWhy the key to commercialization is about looking beyond the tech and focusing instead on problemsPlans and predictions for Pittsburgh's industry in the next five years Enjoying the show? Please leave us a review here. Even one sentence helps. It's feedback from Manufacturing All-Stars like you that keeps us going!Tweetable Quotes:"I think it's just really important that you stop being obsessed with the technology... rather than being inspired by the technology, be inspired by the problem that it's solving."“Like any kind of industrial revolution, this is going to be largely highly disruptive to all humans. Society is going to change. People are going to change, businesses are going to change. Are you on the right side of that change?”“Commercialization is key. The world is sitting by waiting to see what robotics and autonomy look like at scale. How do you take something and not need it to be custom-built?”Links & mentions:Pittsburgh Robotics Network, a community that connects more than 125 advanced technology companies across multiple industriesIndustrial Solutions Network, an interconnected group of manufacturing technology companies working on a common missionGrapperia Pittsburgh, a cocktail bar with a huge selection of speciality cocktails, grappa and amariUmami Izakaya, a Japanese restaurant and bar serving modern Asian cuisine in PittsburghArsenal Bowl, originally Arsenal Lanes, this bowling alley combines unique décor with live music and...

With all the data at our fingertips, why do so many companies still struggle to deliver truly personalized experiences at scale? Agility requires being able to cut through the noise of data and culture shifts to deliver experiences that truly resonate with each individual.Today we're going to talk about personalization maturity, the role of machine learning, deep learning, and generative AI in driving relevance, and how to future-proof your martech stack with open, flexible architectures that enable best-in-class personalization. To help me discuss this topic, I'd like to welcome Yaniv Navot, Former Dynamic Yield by Mastercard CMO and current SVP of Commercialization for Customer Acquisition & Engagement at Mastercard. About Yaniv Navot Former Dynamic Yield by Mastercard CMO and current SVP of Commercialization for Customer Acquisition & Engagement. He is marketing leader and personalization expert with nearly two decades of experience driving performance-driven marketing at scale. He shaped the personalization market and led the company's rise as an industry leader. Joining as the first marketing hire, Yaniv built a world-class team and partnered with top B2C brands to deliver impactful, cutting-edge personalization strategies. Follow him on LinkedIn: @yanivnavot. Yaniv Navot on LinkedIn: https://www.linkedin.com/in/yanivnavot/ Resources Mastercard: https://www.mastercard.com https://www.mastercard.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow Catch the future of e-commerce at eTail Boston, August 11-14, 2025. Register now: https://bit.ly/etailboston and use code PARTNER20 for 20% off for retailers and brandsDon't Miss MAICON 2025, October 14-16 in Cleveland - the event bringing together the brights minds and leading voices in AI. Use Code AGILE150 for $150 off registration. Go here to register: https://bit.ly/agile150" Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstromDon't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.showCheck out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company